For over 20 years, Diaceutics has helped pharma and biotech close the gap between testing and treatment by connecting real-world data, global diagnostic expertise, and clinically trusted physician engagement through DXRX, the world’s first diagnostic commercialization platform. Their purpose is clear: ensuring every eligible patient receives the right therapy at precisely the right time.
MassBio Member Spotlight: Diaceutics
Location: New Jersey
Business type: Data analytics and end-to-end services provider for the development and commercialisation of precision medicine diagnostics.
Leadership:
Ryan Keeling – CEO
Susan Munksted – Chief Precision Medicine Officer
Jordan Clarke – Chief Data Officer